A Study of Apatinib in Patients With Advanced Hepatocellular Carcinoma

Clinical trial NCT01192971 · COMPLETED

Trial details

NCT number: NCT01192971
Sponsor: Jiangsu HengRui Medicine Co., Ltd.
Status: COMPLETED
Phase: Phase 2
Study type: INTERVENTIONAL

Advanced Hepatocellular Carcinoma

Start date: 2010-06-01
Primary completion: 2013-07-01
Enrollment: 121

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.